{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "sharesOutstanding": 18145800, "bookValue": -1.174, "fiftyDayAverage": 0.0025, "fiftyDayAverageChange": 0.0, "fiftyDayAverageChangePercent": 0.0, "twoHundredDayAverage": 0.0024395, "twoHundredDayAverageChange": 6.049988e-05, "twoHundredDayAverageChangePercent": 0.024800114, "marketCap": 2867025, "priceToBook": -0.0021294719, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "exchange": "PNK", "shortName": "PARNELL PHARMACEUTICALS HLDGS L", "longName": "Parnell Pharmaceuticals Holdings Ltd", "messageBoardId": "finmb_260909193", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.0025, "firstTradeDateMilliseconds": 1403098200000, "priceHint": 4, "regularMarketChange": 0.0, "regularMarketTime": 1683135336, "regularMarketDayHigh": 0.0025, "regularMarketDayRange": "0.0025 - 0.0025", "regularMarketDayLow": 0.0025, "regularMarketVolume": 2500, "regularMarketPreviousClose": 0.0025, "fullExchangeName": "Other OTC", "financialCurrency": "AUD", "regularMarketOpen": 0.0025, "averageDailyVolume3Month": 132, "averageDailyVolume10Day": 250, "fiftyTwoWeekLowChange": 0.00049999985, "fiftyTwoWeekLowChangePercent": 0.24999991, "fiftyTwoWeekRange": "0.002 - 0.0026", "fiftyTwoWeekHighChange": -0.00010000006, "fiftyTwoWeekHighChangePercent": -0.038461562, "fiftyTwoWeekLow": 0.002, "fiftyTwoWeekHigh": 0.0026, "earningsTimestamp": 1554508800, "earningsTimestampStart": 1585958400, "earningsTimestampEnd": 1586304000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 0.0, "displayName": "Parnell Pharmaceuticals", "symbol": "PARNF"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Century Estate", "address2": "Unit 4 476 Gardeners Road", "city": "Alexandria", "state": "NSW", "zip": "2015", "country": "Australia", "phone": "61 2 9667 4411", "fax": "61 2 9667 4139", "website": "https://www.parnell.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Alan Richard Bell", "age": 66, "title": "Exec. Chairman", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Brad R. McCarthy CPA", "age": 46, "title": "CEO, CFO, Chief Accounting Officer, Company Sec. & Exec. Director", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}